Effect of Eye Make up on Ocular Surface
Sponsor
Erol Olcok Corum Training and Research Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT04478955
Collaborator
(none)
80
1
1
78.5
Study Details
Study Description
Brief Summary
The aim of this study is to compare the degree of tear film instability and severity of meibomian gland loss between subjects who use eyeliner, mascara, a combination of both and those who do not use eyeliner.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
80 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Effect of Pencil Eyeliners and Waterproof Mascara on Tear Stability Tests and Meibomography
Actual Study Start Date
:
Jul 1, 2020
Anticipated Primary Completion Date
:
Jul 29, 2020
Anticipated Study Completion Date
:
Aug 1, 2020
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
normal no make up |
Diagnostic Test: Schirmer test
Tear tests Meibomian gland grading test
Other Names:
|
eyeliner only three days a week at least for 6 months |
Diagnostic Test: Schirmer test
Tear tests Meibomian gland grading test
Other Names:
|
mascara only three days a week at least for 6 months |
Diagnostic Test: Schirmer test
Tear tests Meibomian gland grading test
Other Names:
|
eyeliner and mascara three days a week at least for 6 months |
Diagnostic Test: Schirmer test
Tear tests Meibomian gland grading test
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Schirmer test [5 minutes]
Tear measurement
Secondary Outcome Measures
- Non contact tear break up test [17 seconds]
tear stability calculation
- Meibomography [2 minutes]
Meibomian gland loss grading
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 35 Years
Sexes Eligible for Study:
Female
Inclusion Criteria:
To use eyeliner/mascara or combined for at least 3 days for 6 months for study groups No routine eye make up use for the cıontrol group
-
Exclusion Criteria:
- any systemic or ocular disease taht can affect ocular surface
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ErolOlcok Corum WEducatin and Research Hospital | Corum | Turkey | 19000 |
Sponsors and Collaborators
- Erol Olcok Corum Training and Research Hospital
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Zeynep Eylül Ercan,
Doctor,
Erol Olcok Corum Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT04478955
Other Study ID Numbers:
- Corum State Hospital
First Posted:
Jul 21, 2020
Last Update Posted:
Jul 21, 2020
Last Verified:
Jul 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Zeynep Eylül Ercan,
Doctor,
Erol Olcok Corum Training and Research Hospital
Additional relevant MeSH terms: